Trial Profile
Phase III Study of NRD101: A confirmatory study of NRD101 in patients with periarthritis scapulohumeralis
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 07 Jan 2022
Price :
$35
*
At a glance
- Drugs Hyaluronic acid (Primary)
- Indications Frozen shoulder; Periarthritis
- Focus Therapeutic Use
- Sponsors Chugai Pharmaceutical
- 10 Jul 2017 Status changed from not yet recruiting to recruiting.
- 24 Mar 2017 New trial record